A product must pass all four to appear on this list
doi: 10.1016/j.jfms.2009.04.004
Potential drug interactions Sermorelin has no known major drug interactions, but may have the following interactions with certain drugs: Glucocorticoids (prednisone) May blunt growth hormone (GH) release Oral estrogens May increase IGF-1 resistance Insulin or sulfonylureas May alter glycemic control Somatostatin analogs May antagonize Sermorelins effects Dopamine antagonists May disrupt human growth hormone (HGH) regulation GABAergic meds May reduce pulsatility of HGH release Beta blockers (Metoprolol or Propranolol) Other secretagogues/peptides May result in unsafe levels of HGH Other important safety information Sermorelin is only for patients who are at least 30 years old
Consulting a peptide half-life chart before initiating these protocols prevents the common error of applying short-acting dosing schedules to long-acting compounds
Stay ready, stay balanced, and support your performanceevery step of the way
Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, et al